Can You Have Osteoarthritis and Rheumatoid Arthritis at the Same Time?

You can absolutely have osteoarthritis and rheumatoid arthritis at the same time, and it is more common than most people realize. In fact, among elderly patients with rheumatoid arthritis, radiographic signs of osteoarthritis show up in over 60% of them, with the knee being the most frequently affected joint.¹ The two diseases arise from entirely different processes, but they target the same structures and can coexist in the same person or even the same joint. That overlap creates real challenges for diagnosis, pain management, and treatment planning.

Why Having Both Is So Common

Osteoarthritis is primarily a wear-and-tear condition. Cartilage breaks down over time, bone spurs form, and joints get stiff and painful. Rheumatoid arthritis is an autoimmune disease in which the immune system attacks the synovial lining of joints, causing inflammation, swelling, and eventually joint damage. They are different diseases with different causes, but they both affect joints, and they both become more likely as you age. Since osteoarthritis affects a huge proportion of the population over 50 and rheumatoid arthritis can strike at any adult age, the sheer probability of overlap grows as someone with RA gets older.

But it is not just coincidence. Research shows that RA itself accelerates the development of what doctors call “secondary osteoarthritis.” In patients with anti-citrullinated protein antibody-positive RA, age, disease duration, and bone erosions are all linked to the development of osteophytes, the bony spurs characteristic of osteoarthritis.² In other words, the joint damage RA causes can itself trigger osteoarthritic changes. Chronic inflammation alters the mechanical environment of a joint, and once cartilage and bone are disrupted, the degenerative process associated with OA can set in on top of the inflammatory process.

Research into knee OA in RA patients has identified several risk factors that speed this along. Long-term use of glucocorticoids (steroids) and high RA disease activity each independently raise the risk of developing secondary knee OA, with steroids associated with roughly a fivefold increase and high disease activity roughly a 3.5-fold increase. Being over 45 and having RA for more than ten years are additional risk factors.³ So having RA for a long time, especially if it has been difficult to control, makes it increasingly likely that osteoarthritis will eventually show up as well.

How Doctors Tell Them Apart in the Same Person

When both conditions are present, figuring out which disease is responsible for which symptoms becomes genuinely tricky. The classic distinction between the two relies heavily on patterns that stop being so clean-cut once someone has both. RA tends to cause symmetric swelling in the small joints of the hands and feet, with prolonged morning stiffness that improves with movement. OA stiffness tends to be shorter-lived, worse with activity, and better with rest.⁴ But when both are happening simultaneously, a patient might report morning stiffness that partly fits one pattern and partly the other, with pain at rest and pain with movement overlapping in confusing ways.

Blood tests help, but only to a point. Rheumatoid factor and anti-CCP antibodies are strongly associated with RA, and in patients with osteoarthritis these autoimmune markers tend to be very low or absent. A large retrospective analysis of over 2,600 patients confirmed that biomarker positivity was minimal in the OA subgroup, giving these tests strong ability to distinguish the two conditions.⁵ That is helpful if you are trying to determine whether someone has RA in the first place. But once RA is already established, blood work does not tell you whether a specific knee or hip joint is painful because of ongoing RA inflammation or because of secondary OA.

Imaging becomes the more important tool for sorting this out. On X-rays, MRI, and ultrasound, the two conditions look quite different at the tissue level. OA produces pronounced osteophytes, the bony growths at joint margins. RA produces bone erosions, where the inflammatory process eats into bone. Fusion imaging techniques using MRI and ultrasound together can clearly distinguish the bony profiles of each condition.⁶ When a single joint shows both erosions and osteophytes, that is a strong signal that both diseases are at work.

The Mismatch Between Imaging and Symptoms

One of the more frustrating aspects of having both conditions is that what shows up on imaging does not always match what a person feels. Among elderly RA patients, a cross-sectional study found that while radiographic OA was present in about 62% of subjects, only about 22% had symptomatic OA.¹ That means a large share of RA patients have X-ray evidence of osteoarthritis in their knees without reporting additional pain from it. Whether that is because RA pain masks OA pain, or because the OA changes are simply too mild to produce symptoms on their own, is not entirely clear.

This discordance matters for treatment decisions. If a doctor sees OA changes on imaging and assumes they are driving a patient’s knee pain, the treatment plan might lean toward physical therapy and anti-inflammatories. But if the real culprit is a flare of RA inflammation, the patient needs disease-modifying antirheumatic drugs (DMARDs) adjusted, not just pain management. Getting it wrong means the patient stays in pain while the underlying cause goes unaddressed.

When Pain Does Not Match Either Diagnosis

To make matters more complicated, pain that persists in someone with well-controlled RA is not always from RA or from OA. Researchers have recognized what they call “residual pain,” which can include secondary pain syndromes like osteoarthritis and fibromyalgia, as well as neuropathic and nociplastic pain that does not correlate neatly with inflammation or structural damage.⁷ Standard measures of RA disease activity recommended by professional bodies like EULAR can miss these pain contributions, which means a patient might score as being in remission on paper while still experiencing significant joint pain.

Both OA and RA share features of central sensitization, a process where the nervous system amplifies pain signals regardless of what is happening in the joints themselves. Quantitative sensory testing shows similar patterns and degrees of sensitization in both disease groups compared to healthy controls.⁸ Central sensitization can cause heightened sensitivity to touch, pain that spreads beyond the affected joint, and pain that seems out of proportion to the visible disease. When someone has both OA and RA plus central sensitization layered on top, untangling what is driving their experience of pain becomes genuinely difficult.⁹

What This Means for Daily Treatment

Managing both conditions at once requires balancing two somewhat different treatment philosophies. RA demands aggressive control of inflammation through DMARDs, biologics, and sometimes steroids. OA treatment focuses more on pain relief, physical therapy, and protecting joint function. When someone has both, the RA medications take priority because unchecked inflammation leads to worse outcomes across the board, but the OA component still needs attention.

Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for both conditions. A large randomized trial involving over 24,000 patients with OA or RA found that celecoxib at approved doses carried a similar or lower risk of cardiovascular, gastrointestinal, and kidney problems compared to ibuprofen or naproxen in both patient groups.¹⁰ For patients taking low-dose aspirin for heart protection alongside an NSAID, a systematic review of trials found celecoxib still offered roughly half the rate of stomach ulcers compared to traditional NSAIDs, though the benefit was greater in non-aspirin users.¹¹ For someone managing both OA pain and RA inflammation who is also on aspirin, these details matter when choosing which NSAID to use.

Exercise therapy benefits both conditions. Research confirms that exercise increases aerobic capacity and muscle strength in RA patients without worsening disease activity or pain, and in OA patients it improves pain, strength, and function at least in the short term. The key caveat for someone with both is to avoid high-impact loads and activities with high injury risk.¹² Low-impact activities like swimming, cycling, and walking are the usual recommendations. The optimal frequency and intensity have not been nailed down precisely, but the consensus points toward consistent moderate activity rather than sporadic intense sessions.

Joint Replacement When Both Diseases Are Present

When joint damage from either or both conditions reaches a point where the joint cannot be saved, total joint replacement becomes an option. Both RA and OA patients undergo hip and knee replacements regularly, but outcomes differ in some important ways for people with RA.

A systematic review and meta-analysis of 40 studies found that RA patients face roughly double the odds of hip dislocation after total hip replacement compared to OA patients. For total knee replacement, the risk of infection and early revision were also higher in RA.¹³ A separate study put more specific numbers on it: the dislocation rate after hip replacement was about 2.5% in RA versus 1.2% in OA, and the infection rate after knee replacement was about 1.3% in RA versus 0.8% in OA.¹⁴ RA patients were also more likely to need blood transfusions and had slightly longer hospital stays and higher costs, though overall complication rates were actually somewhat higher in the OA group once cardiac, kidney, and gastrointestinal events were counted.¹⁵

For someone who has developed OA secondary to long-standing RA, the decision to proceed with joint replacement involves weighing the immunosuppressive medications they take for RA, which can increase infection risk, against the functional benefits of surgery. Surgeons and rheumatologists typically coordinate around these medications, sometimes adjusting or pausing biologic drugs before surgery to reduce infection risk while trying to prevent an RA flare.

How Other Conditions Muddy the Waters

RA and OA are not the only two forms of arthritis that can overlap or be confused with each other. Psoriatic arthritis, in particular, shares features with both. It can involve the same distal finger joints as OA, and it can cause inflammatory joint swelling similar to RA. But psoriatic arthritis tends to be asymmetric and involves the spine more often, and it frequently accompanies psoriatic nail changes.⁴ Among RA patients, the prevalence of psoriatic arthritis is about 3.2%, compared to only 0.4% among OA patients.¹⁶ So a small but meaningful group of people end up juggling three overlapping forms of joint disease.

Emerging metabolomic research, which looks at the chemical fingerprints in joint fluid, is starting to reveal more fundamental differences between these conditions. RA synovial fluid shows elevated markers of inflammatory macrophage activation and metabolic stress. OA fluid, interestingly, is enriched in metabolites produced by gut bacteria, supporting a growing hypothesis about a gut-joint connection in osteoarthritis. Psoriatic arthritis has its own unique metabolic profile distinct from both.¹⁷ These findings are still in the research phase, but they suggest that future diagnostic tools could be more precise about which process is driving joint damage in a given patient.

At the immune-cell level, the synovial compartment also looks different between the two conditions. In OA joints, a specific subset of inflammatory T cells tends to accumulate, while in RA joints, the immune profile is dominated by regulatory T cells and a type associated with antibody production. Inflammatory cytokines like IL-17 are elevated in RA synovial fluid and correlate with autoantibodies and disease activity.¹⁸ Understanding these immune differences may eventually help clinicians determine which disease is more active in a joint that shows signs of both.

Why Getting Diagnosed Takes So Long

Delays in diagnosing inflammatory arthritis conditions like RA are well-documented, and the existence of concurrent OA can make things worse. A study of diagnostic delays in rheumatic diseases found that limited access to specialists and patients’ belief that symptoms would go away on their own were the biggest factors in delayed diagnosis, affecting 70% and 57% of cases respectively.¹⁹ When someone already carries an OA diagnosis and their joint pain worsens or changes character, both the patient and their doctor may attribute the new symptoms to worsening OA rather than considering that RA has entered the picture. The reverse can also happen: someone treated for RA whose medications seem to be working may still have persistent pain in certain joints because OA has developed secondarily, but neither patient nor doctor investigates further because the RA is “controlled.”

The practical lesson is that any change in pain pattern deserves a fresh look. If you have OA and your pain starts behaving differently, showing up with morning stiffness lasting more than 30 minutes, affecting joints symmetrically, or appearing in new small joints, those are red flags worth raising with a rheumatologist. If you have RA and your pain persists despite good control of inflammation on blood work, do not assume the medications are failing. The pain may come from secondary OA, from central sensitization, or from something else entirely that requires a different approach.

The Toll of Carrying Both Diagnoses

Having multiple chronic conditions at once takes a measurable toll on quality of life that goes beyond what either condition alone would cause. In patients with RA or OA, each additional comorbid condition was associated with a significant drop in physical health scores, and even mental health scores declined modestly with each added condition.²⁰ Arthritis severity itself also predicted worse physical functioning. So someone with both RA and OA is not simply dealing with two independent sources of pain; the combined burden compounds in ways that affect energy, mobility, mood, and daily functioning.

Among people 75 and older, pain from RA tends to increase with age and disease duration, while OA pain does not follow the same trajectory as predictably. That asymmetry means the lived experience of having both conditions shifts over time. Early on, RA may dominate the picture with its inflammatory flares. As decades pass and joints accumulate damage, OA takes a larger share of the pain burden, even as RA itself may become less inflammatory. This gradual transition can be disorienting for patients who have spent years learning to manage one disease and suddenly find their pain responding to different triggers and different treatments.